Proliferative drive and liver carcinogenesis: too much of a good thing?
- PMID: 20002941
- DOI: 10.1111/j.1440-1746.2009.06121.x
Proliferative drive and liver carcinogenesis: too much of a good thing?
Abstract
There have been innumerable studies published in the attempt to identify gene expression signatures in hepatocellular carcinoma (HCC). When all the regulators and targets of the differentially expressed genes are analyzed from larger studies, the most striking theme is upregulation of mitosis-promoting and cell proliferation genes in HCC compared with 'liver-specific gene clusters' in non-tumorous tissue. A major limitation of expression profiling is that it only provides a 'snapshot' of what is an evolving process and thus cannot distinguish the differences in gene expression that are primary effectors of dysregulated growth from those that represent downstream consequences. The development of HCC in a chronically diseased liver, often referred to as hepatocarcinogenesis, is a multistep process characterized by the progressive accumulation and interplay of genetic alterations causing aberrant growth, malignant transformation of liver parenchymal cells, followed by vascular invasion and metastasis. This review will discuss HCC precursor lesions, draw on the 'proliferation cluster' genes highlighted from HCC expression profiling studies, relate them to a selection of regulatory networks important in liver regeneration, cell cycle control and their potential significance in the pathogenesis of HCC or primary liver cancer.
Similar articles
-
Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling.Hepatology. 2005 Oct;42(4):809-18. doi: 10.1002/hep.20878. Hepatology. 2005. PMID: 16175600
-
RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.J Gastroenterol Hepatol. 2008 Sep;23(9):1448-58. doi: 10.1111/j.1440-1746.2007.05067.x. Epub 2007 Aug 6. J Gastroenterol Hepatol. 2008. PMID: 17683489
-
Molecular mechanisms of liver carcinogenesis in the mdr2-knockout mice.Mol Cancer Res. 2007 Nov;5(11):1159-70. doi: 10.1158/1541-7786.MCR-07-0172. Mol Cancer Res. 2007. PMID: 18025261
-
Preneoplastic lesions in human hepatocarcinogenesis.Liver Int. 2005 Feb;25(1):16-27. doi: 10.1111/j.1478-3231.2005.01016.x. Liver Int. 2005. PMID: 15698394 Review.
-
Genes involved in hepatocellular carcinoma: deregulation in cell cycling and apoptosis.Virchows Arch. 2002 Apr;440(4):345-52. doi: 10.1007/s00428-002-0617-x. Epub 2002 Mar 6. Virchows Arch. 2002. PMID: 11956813 Review.
Cited by
-
Intracellular signaling and hepatocellular carcinoma.Semin Cancer Biol. 2011 Feb;21(1):28-34. doi: 10.1016/j.semcancer.2010.09.001. Epub 2010 Sep 17. Semin Cancer Biol. 2011. PMID: 20850540 Free PMC article. Review.
-
Aberrant DNA methylation of imprinted loci in hepatocellular carcinoma and after in vitro exposure to common risk factors.Clin Epigenetics. 2015 Feb 27;7(1):15. doi: 10.1186/s13148-015-0053-9. eCollection 2015. Clin Epigenetics. 2015. PMID: 25755686 Free PMC article.
-
SAG-UPS attenuates proapoptotic SARM and Noxa to confer survival advantage to early hepatocellular carcinoma.Cell Death Discov. 2015 Sep 28;1:15032. doi: 10.1038/cddiscovery.2015.32. eCollection 2015. Cell Death Discov. 2015. PMID: 27551463 Free PMC article.
-
The status of zinc in the development of hepatocellular cancer: an important, but neglected, clinically established relationship.Cancer Biol Ther. 2014 Apr;15(4):353-60. doi: 10.4161/cbt.27633. Epub 2014 Jan 21. Cancer Biol Ther. 2014. PMID: 24448510 Free PMC article. Review.
-
Ceramide synthase-4 orchestrates the cell proliferation and tumor growth of liver cancer in vitro and in vivo through the nuclear factor-κB signaling pathway.Oncol Lett. 2017 Aug;14(2):1477-1483. doi: 10.3892/ol.2017.6365. Epub 2017 Jun 9. Oncol Lett. 2017. PMID: 28789368 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical